(2018). Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis. Respir Res. http://doi.org/10.1186/s12931-018-0742-y.
(2019). One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta2-agonist in UK primary care settings. Respir Med. http://doi.org/10.1016/j.rmed.2019.105859.
(2021). Asthma phenotyping in primary care: applying the International Severe Asthma Registry eosinophil phenotype algorithm across all asthma severities. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2021.07.056.